BioCentury
ARTICLE | Clinical News

MiReven, Silence Therapeutics preclinical data

February 18, 2013 8:00 AM UTC

In vitro, miR-7-5p significantly inhibited the migration and invasion of metastatic melanoma cells. The product is a miRNA targeting insulin receptor substrate 2 (IRS2), an activator of protein kinas...